CCR

CC chemokine receptor (CCR) antagonists block G protein-coupled receptors that guide leukocyte migration. CCR2, a receptor for monocyte chemoattractant protein 1 (MCP-1), was cloned in 1994 as two splice variants. CCR5 was identified in 1996 as a fusion cofactor for macrophage-tropic human immunodeficiency virus type 1 (HIV-1). Maraviroc, described in 2005 as a selective small-molecule CCR5 inhibitor, blocks this route of viral entry. Other CCR5 antagonists include vicriviroc malate and aplaviroc, while INCB3344 and MK-0812 target CCR2. Cenicriviroc blocks both CCR2 and CCR5, and GSK2239633A is a CCR4 antagonist for studies of T cell trafficking.

Items 76-100 of 154

  • CCR4 antagonist 4
    Cat. No.
    A59519

    CCR4 antagonist 4

    CCR4 Antagonist 4 is a selective and potent inhibitor of the CC chemokine receptor-4 (CCR4), exhibiting an IC50 of 0.02 μM. This compound effectively blocks MDC-mediated chemotaxis and Ca2+ mobilization, with IC50 values of 0.007 μM and 0.003 μM, respectively. CCR4 Antagonist 4 is valuable for investigations into allergic inflammation mechanisms and related therapeutic applications.

    5 mg
    $370.00
    10 mg
    $610.00
    All 5 sizes
  • CCR8 antagonist 1
    Cat. No.
    A59521

    CCR8 antagonist 1

    CCR8 antagonist 1 is a potent antagonist of human CCR8, exhibiting an inhibition constant (Ki) of 1.6 nM. This compound demonstrates high safety and metabolic stability, making it suitable for in vitro and in vivo studies. CCR8 antagonist 1 is valuable for researching conditions such as asthma and multiple sclerosis, where CCR8-mediated pathways play a significant role in disease progression.

    1 mg
    $40.00
    5 mg
    $90.00
    All 6 sizes
  • AZD2423
    Cat. No.
    A59522

    AZD2423

    AZD2423 functions as a negative allosteric modulator of the CCR2 chemokine receptor, exhibiting potent selectivity and oral bioavailability. With an IC50 value of 1.2 nM for CCR2-mediated Ca2+ flux, this compound is valuable for investigating the role of CCR2 in various physiological and pathological processes. AZD2423 is useful in research applications related to inflammation, cancer, and immune system modulation.

    5 mg
    $615.00
    10 mg
    $1,010.00
    All 5 sizes
  • CCX354
    Cat. No.
    A59523

    CCX354

    CCX354 is a CCR1 antagonist that primarily functions by inhibiting the receptor's signaling pathways, leading to a reduction in inflammatory responses. This compound demonstrates significant anti-inflammatory activity, making it a valuable tool for research into inflammatory diseases and conditions where CCR1-mediated signaling is implicated. Researchers can utilize CCX354 to explore mechanisms of inflammation and potential therapeutic strategies targeting CCR1.

    1 mg
    $125.00
    5 mg
    $290.00
    All 6 sizes
  • CCR1 antagonist 9
    Cat. No.
    A59524

    CCR1 antagonist 9

    CCR1 antagonist 9 is a potent and selective antagonist of the CCR1 receptor, exhibiting an IC50 of 6.8 nM in calcium flux assays. This compound plays a significant role in research related to inflammatory responses and immune system modulation. CCR1 antagonist 9 is valuable in studying the impact of CCR1 inhibition in various disease models including autoimmune and chronic inflammatory conditions.

    1 mg
    $80.00
    5 mg
    $205.00
    All 6 sizes
  • BMS-817399
    Cat. No.
    A59525

    BMS-817399

    BMS-817399 is a selective CCR1 antagonist that demonstrates high potency with a binding affinity IC50 of 1 nM and chemotaxis inhibition at 6 nM. This compound is orally bioavailable, making it suitable for in vivo studies. BMS-817399 is primarily utilized in research related to rheumatoid arthritis, providing insights into the modulation of inflammatory responses mediated by CCR1.

    1 mg
    $80.00
    5 mg
    $175.00
    All 6 sizes
  • CCR3 antagonist 1
    Cat. No.
    A59526

    CCR3 antagonist 1

    CCR3 Antagonist 1 is a potent antagonist of the CCR3 receptor, which plays a critical role in the pathogenesis of immunologic and inflammatory diseases. This compound is instrumental in studying the modulation of immune responses and the development of therapeutic strategies targeting CCR3-mediated signaling pathways. Its application is pivotal for researchers investigating conditions such as asthma, allergic responses, and other related disorders.

    1 mg
    $75.00
    5 mg
    $160.00
    All 6 sizes
  • ALK4290
    Cat. No.
    A59527

    ALK4290

    Synonyms: AKST4290

    ALK4290 is a potent, orally active inhibitor of CCR3, exhibiting a Ki of 3.2 nM for human CCR3. Its biological activity positions ALK4290 as a valuable tool for research into neovascular age-related macular degeneration and Parkinsonism. This compound may help elucidate the role of CCR3 in these diseases, facilitating the development of targeted therapeutic strategies.

    5 mg
    $535.00
    10 mg
    $825.00
    All 5 sizes
  • MLN3126
    Cat. No.
    A59528

    MLN3126

    MLN3126 is a potent CCR9 antagonist that exhibits significant oral bioavailability. It effectively inhibits CCL25-induced calcium mobilization and the chemotaxis of mouse primary thymocytes, demonstrating an IC50 value of 6.3 nM for calcium influx. This compound is valuable for research applications investigating immune cell trafficking and related pathways in inflammatory conditions.

    5 mg
    $205.00
    10 mg
    $335.00
    All 5 sizes
  • AZD-1678
    Cat. No.
    A59529

    AZD-1678

    AZD-1678 is a potent antagonist of the CCR4 receptor, exhibiting a pIC50 of 8.6. This compound demonstrates significant biological activity in inhibiting CCR4-mediated signaling pathways, making it useful for research focused on immune response modulation and cancer immunotherapy. Its specificity for the CCR4 receptor allows for detailed studies in related disease models, enhancing our understanding of targeted therapeutic strategies.

    5 mg
    $695.00
    10 mg
    $925.00
    All 5 sizes
  • CCR4-351
    Cat. No.
    A59531

    CCR4-351

    CCR4-351 is a potent and selective antagonist of the CCR4 receptor. With IC50 values of 22 nM and 50 nM in the calcium flux and CTX assays, respectively, this compound demonstrates significant biological activity. CCR4-351 is primarily utilized in research applications exploring its antitumor effects and potential therapeutic benefits in modulating immune responses.

    1 mg
    $265.00
    5 mg
    $675.00
    All 6 sizes
  • Tagmokitug
    Cat. No.
    A59532

    Tagmokitug

    Synonyms: CHS-114; SRF-114

    Tagmokitug (CHS-114) is a fully human IgG1 antibody that specifically targets the CCR8 receptor. This antibody is valuable for researching head and neck squamous cell carcinoma (HNSCC) and understanding the role of CCR8 in tumor microenvironments. Researchers can utilize Tagmokitug to investigate CCR8-mediated signaling pathways and their implications in cancer progression.

    1 mg
    $225.00
    5 mg
    $690.00
    All 4 sizes
  • PF-04634817 succinate
    Cat. No.
    A59533

    PF-04634817 succinate

    PF-04634817 succinate is a potent dual antagonist of the CCR2 and CCR5 receptors, demonstrating comparable efficacy in human and rodent CCR2 with an IC50 of 20.8 nM in rats, while exhibiting a reduced potency for CCR5 (IC50 of 470 nM). This compound is suitable for investigating the role of these receptors in various biological pathways, particularly in the context of diabetic nephropathy. PF-04634817 succinate is an important tool for researchers exploring inflammatory and fibrotic processes associated with chronic kidney disease.

    1 mg
    $105.00
    5 mg
    $285.00
    All 6 sizes
  • JNJ-41443532
    Cat. No.
    A59534

    JNJ-41443532

    Synonyms: CCR2 antagonist 5

    JNJ-41443532 is a selective antagonist of the human CCR2 receptor, exhibiting an IC50 of 37 nM for binding and demonstrating potent functional antagonism with an IC50 of 30 nM in chemotaxis assays. This compound shows a Ki value of 9.6 µM for murine CCR2 binding. JNJ-41443532 is suitable for research into inflammatory diseases and related inflammatory pathways.

    1 mg
    $80.00
    5 mg
    $205.00
    All 7 sizes
  • cis-INCB3344
    Cat. No.
    A59535

    cis-INCB3344

    Cis-INCB3344 is the isomer of INCB3344 and serves as an experimental control in research. INCB3344 is recognized as a potent and selective antagonist of the CCR2 receptor, exhibiting binding antagonism with IC50 values of 5.1 nM for human CCR2 and 9.5 nM for mouse CCR2. Additionally, it demonstrates effective chemotaxis inhibition with IC50 values of 3.8 nM for human CCR2 and 7.8 nM for mouse CCR2. This compound is useful in studies focusing on inflammatory responses and related pathways.

    5 mg
    $100.00
    10 mg
    $160.00
    All 4 sizes
  • CCR4-351 hydrochloride
    Cat. No.
    A59536

    CCR4-351 hydrochloride

    CCR4-351 hydrochloride is a selective antagonist of the CCR4 receptor. This compound exhibits potent biological activity with IC50 values of 22 nM in the calcium flux assay and 50 nM in the CTX assay. Its antagonistic properties make CCR4-351 hydrochloride a valuable tool for research in cancer biology and therapeutic development, particularly in exploring its antitumor effects.

    1 mg
    $265.00
    5 mg
    $675.00
    All 3 sizes
  • JNJ-27141491
    Cat. No.
    A59537

    JNJ-27141491

    JNJ-27141491 is a selective noncompetitive antagonist of the human chemokine receptor CCR2. It inhibits CCR2-mediated signaling, making it a valuable tool for studying immune responses and inflammation. This compound is useful in research applications focused on cardiovascular diseases and cancer, where CCR2 plays a significant role in immune cell recruitment and tissue remodeling.

    1 mg
    $355.00
    5 mg
    $1,095.00
    All 6 sizes
  • AZD-5672
    Cat. No.
    A59538

    AZD-5672

    AZD-5672 is a potent and selective antagonist of the CCR5 receptor, exhibiting an IC50 of 0.32 nM. This compound demonstrates moderate activity against the hERG ion channel with a binding IC50 of 7.3 μM and acts as a substrate for human P-glycoprotein, inhibiting P-gp-mediated digoxin transport with an IC50 of 32 μM. AZD-5672 is an effective tool for investigating the role of CCR5 in inflammatory diseases, including rheumatoid arthritis.

    1 mg
    $100.00
    5 mg
    $240.00
    All 6 sizes
  • Met-RANTES (human)
    Cat. No.
    A59539

    Met-RANTES (human)

    Synonyms: MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSN

    Met-RANTES (human) is a potent antagonist of the CCR5 chemokine receptor, demonstrating significant inhibitory activity against human MIP-1α and MIP-1β with IC50 values of 5 nM and 2 nM, respectively. This compound has been shown to effectively reduce bone destruction and improve symptoms in models of adjuvant-induced arthritis in rats. Its application in research may provide valuable insights into inflammatory pathways and therapeutic strategies for diseases involving CCR5 signaling.

    Out of stock

    All 3 sizes
  • (1S)-CCR2 antagonist 1
    Cat. No.
    A59540

    (1S)-CCR2 antagonist 1

    (1S)-CCR2 antagonist 1 is a selective antagonist targeting the CCR2 receptor. It demonstrates high-affinity binding with a Ki value of 2.4 nM, indicating its potential effectiveness in modulating CCR2-mediated biological processes. This compound is primarily utilized in research applications focused on inflammation, neurodegenerative diseases, and cancer, where CCR2 signaling plays a significant role. Its long residence time enhances its suitability for in vivo studies and therapeutic developments.

    5 mg
    $560.00
    10 mg
    $925.00
    All 4 sizes
  • CCR4 antagonist 3
    Cat. No.
    A59541

    CCR4 antagonist 3

    CCR4 antagonist 3 is a selective antagonist of chemokine receptor 4 (CCR4) with an IC50 value of 1.7 μM for radiolabeled thymus and activation-regulated chemokine (TARC). This compound effectively inhibits the binding of TARC and macrophage-derived chemokine (MDC) to CCR4 receptors on CEM cell surfaces. Additionally, CCR4 antagonist 3 reduces the in vitro migration of CEM cells induced by TARC, with an IC50 of 6.4 μM. This reagent is valuable for studies investigating CCR4-related immune responses and potential therapeutic interventions in diseases involving CCR4 signaling.

    1 mg
    $75.00
    5 mg
    $185.00
    All 7 sizes
  • BMS-681
    Cat. No.
    A59543

    BMS-681

    BMS-681 is an orthosteric antagonist of the CC chemokine receptor 2 (CCR2). It effectively inhibits receptor activity by stabilizing transmembrane helix 7, thereby influencing the conformation of transmembrane helix 6, which is pivotal to the orthosteric binding site. This compound is valuable for research into inflammatory neurodegenerative diseases and cancer, allowing for investigations into CCR2-mediated signaling pathways and potential therapeutic interventions.

    Out of stock

    All 3 sizes
  • CCR1 antagonist 6
    Cat. No.
    A59544

    CCR1 antagonist 6

    CCR1 antagonist 6 is a selective antagonist of chemokine receptor 1 (CCR1), exhibiting an impressive IC50 of 3 nM. This compound is instrumental in research applications focused on inflammatory responses and immune modulation. Its ability to inhibit CCR1 makes it a valuable tool for investigating the role of this receptor in various disease models, including autoimmune and chronic inflammatory disorders.

    1 mg
    $130.00
    5 mg
    $310.00
    All 7 sizes
  • CCR1 antagonist 7
    Cat. No.
    A59545

    CCR1 antagonist 7

    CCR1 antagonist 7 (compound 16r) is a selective antagonist of chemokine receptor 1 (CCR1), exhibiting an IC50 of 4 nM. This compound effectively inhibits CCR1 signaling, making it valuable for studies exploring chemokine-related inflammatory processes and immune responses. Its application extends to research in various disease models, including autoimmune disorders and cancer.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • BMS-753426
    Cat. No.
    A59546

    BMS-753426

    BMS-753426 is a potent antagonist of the chemokine receptor CCR2. It effectively inhibits CCR2-mediated signaling, making it a valuable tool for research into inflammatory and autoimmune diseases. This compound is particularly relevant for studies investigating the role of chemokines in immune cell migration and related pathophysiological processes.

    5 mg
    $795.00
    All 1 sizes

Items 76-100 of 154

Added to your cart

View Cart Checkout

    Loading...